Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors

被引：0
|
作者：
Yi Wang
Gui-Qi Zhu
Chang-Wu Zhou
Na Li
Chun Yang
Meng-Su Zeng
机构：
[1] Fudan University,Department of Radiology, Zhongshan Hospital, Shanghai Institute of Medical Imaging
[2] Fudan University,Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital
来源：
European Radiology | 2022年 / 32卷
关键词：
Liver neoplasms; Magnetic resonance imaging; Risk stratification; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5166 / 5178
页数：12
相关论文
共 50 条
  • [41] Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma
    Cannella, Roberto
    Matteini, Francesco
    Burgio, Marco Dioguardi
    Sartoris, Riccardo
    Beaufrere, Aurelie
    Calderaro, Julien
    Mule, Sebastien
    Reizine, Edouard
    Luciani, Alain
    Laurent, Alexis
    Seror, Olivier
    Ganne-Carrie, Nathalie
    Wagner, Mathilde
    Scatton, Olivier
    Vilgrain, Valerie
    Cauchy, Francois
    Hobeika, Christian
    Ronot, Maxime
    RADIOLOGY, 2024, 310 (02)
  • [42] GALAD SCORE IS USEFUL FOR RISK STRATIFICATION OF HCC DEVELOPMENT IN PATIENTS WITH LI-RADS 3 OR 4 LESIONS
    Liang, Jeff
    Yeo, Yee Hui
    Noureddin, Mazen
    Ayoub, Walid S.
    Kuo, Alexander
    Sundaram, Vinay
    Todo, Tsuyoshi
    Kim, Irene
    Voidonikolas, Georgios
    Brennan, Todd V.
    Wisel, Steven
    Kosari, Kambiz
    Saouaf, Rola
    Nissen, Nicholas
    Yang, Ju Dong
    HEPATOLOGY, 2022, 76 : S1432 - S1433
  • [43] Reply to "Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma"
    Cannella, Roberto
    Zins, Marc
    Brancatelli, Giuseppe
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 698 - 699
  • [44] CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
    Lv, Kun
    Cao, Xin
    Dong, Yinlei
    Geng, Daoying
    Zhang, Jun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
  • [45] LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma
    Fowler, Kathryn J.
    Potretzke, Theodora A.
    Hope, Thomas A.
    Costa, Eduardo A.
    Wilson, Stephanie R.
    ABDOMINAL RADIOLOGY, 2018, 43 (01) : 149 - 157
  • [46] CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
    Zhou, Yan
    Yin, Shanshan
    Zhao, Lin
    Zhang, Xiang
    Li, Meng
    Ding, Jianmin
    Yan, Kun
    Jing, Xiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma
    Kathryn J. Fowler
    Theodora A. Potretzke
    Thomas A. Hope
    Eduardo A. Costa
    Stephanie R. Wilson
    Abdominal Radiology, 2018, 43 : 149 - 157
  • [48] Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5 Response
    Goins, Stacy M.
    Jiang, Hanyu
    van der Pol, Christian B.
    Salameh, Jean-Paul
    Lam, Eric
    Adamo, Robert G.
    McInnes, Matthew D. F.
    Costa, Andreu F.
    Tang, An
    Alhasan, Ayman S.
    Allen, Brian C.
    Reiner, Caecilia S.
    Clarke, Christopher
    Cerny, Milena
    Wang, Jin
    Choi, Sang Hyun
    Fraum, Tyler J.
    Ludwig, Daniel R.
    Song, Bin
    Joo, Ijin
    Kang, Zhen
    Kierans, Andrea S.
    Kim, So Yeon
    Kwon, Heejin
    Kim, So Yeon
    Kwon, Heejin
    Ronot, Maxime
    Podgorska, Joanna
    Rosiak, Grzegorz
    Song, Ji Soo
    Bashir, Mustafa R.
    RADIOLOGY, 2024, 312 (02) : 1 - 2
  • [49] LI-RADS category 3, 4, and M observations: a multiple parameters diagnostic model for hepatocellular carcinoma
    Chen, Jianwei
    Chen, Huizhen
    Zheng, Dechun
    Yan, Chuan
    Ye, Rongping
    Wen, Liting
    Li, Yueming
    ACTA RADIOLOGICA, 2023, 64 (12) : 2977 - 2986
  • [50] RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH INDETERMINATE (LI-RADS 3) LIVER OBSERVATIONS
    Arvind, Ashwini
    Joshi, Sagar
    Zaki, Timothy
    Burkholder, Daniel A.
    Yokoo, Takeshi
    Fetzer, David
    Browning, Travis
    Rich, Nicole E.
    Marrero, Jorge A.
    Yopp, Adam C.
    Gopal, Purva
    Parikh, Neehar D.
    Singal, Amit G.
    HEPATOLOGY, 2021, 74 : 668A - 669A
12345